Ubs Group Ag Sellas Life Sciences Group, Inc. Transaction History
Ubs Group Ag
- $528 Billion
- Q1 2025
A detailed history of Ubs Group Ag transactions in Sellas Life Sciences Group, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 62,231 shares of SLS stock, worth $120,728. This represents 0.0% of its overall portfolio holdings.
Number of Shares
62,231
Previous 127,821
51.31%
Holding current value
$120,728
Previous $129,000
48.06%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding SLS
# of Institutions
52Shares Held
14.5MCall Options Held
538KPut Options Held
26.3K-
Anson Funds Management LP Dallas, TX7.58MShares$14.7 Million1.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.84MShares$5.51 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA820KShares$1.59 Million0.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA689KShares$1.34 Million0.0% of portfolio
-
Black Rock Inc. New York, NY430KShares$834,9130.0% of portfolio
About SELLAS Life Sciences Group, Inc.
- Ticker SLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,551,900
- Market Cap $39.9M
- Description
- SELLAS Life Sciences Group, Inc., a late-stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for various cancer indications in the United States. Its lead product candidate is galinpepimut-S (GPS), a cancer immunotherapeutic agent that targets Wilms tumor 1, which is in Phase III clinical trials for the tr...